Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Karl Skorecki

Showing results (1-10 of 134) with videos related to

Pageof 14
Sort By:
Journal of the American Society of Nephrology : JASN|June 16, 2018
Leveraging Ancestral Heterogeneity to Map Shared Genetic Risk Loci in Pediatric Steroid-Sensitive Nephrotic SyndromeRebecca Hjorten, Karl Skorecki
Cells|July 11, 2025
Apolipoprotein L1 (APOL1): Consideration of Molecular Evolution, Interaction with APOL3, and Impact of Splice Isoforms Advances Understanding of Cellular and Molecular Mechanisms of Cell InjuryRazi Khalaila, Karl Skorecki
Nature Reviews. Nephrology|March 24, 2019
Introducing routine genetic testing for patients with CKDAsaf Vivante, Karl Skorecki
Discovery Medicine|August 14, 2010
A novel experimental platform for investigating tumorigenesis and anti-cancer therapy in a human microenvironment derived from embryonic stem cellsMaty Tzukerman, Karl Skorecki
Human Genetics|October 12, 2012
The population genetics of the Jewish peopleHarry Ostrer, Karl Skorecki
Lancet (London, England)|May 13, 2017
Israel: health and beyondKarl Skorecki, Richard Horton
Lancet (London, England)|November 7, 2024
Concerns regarding Gaza mortality estimatesRafael Beyar, Karl Skorecki
Kidney International|May 25, 2018
"Biomarking" the transition from genetic risk to kidney diseaseEtty Kruzel-Davila, Karl Skorecki
Clinical Journal of the American Society of Nephrology : CJASN|June 7, 2014
Gene-gene and gene-environment interactions in apolipoprotein L1 gene-associated nephropathyBarry I Freedman, Karl Skorecki
Elife|July 4, 2017
The double-edged sword of evolutionEtty Kruzel-Davila, Karl Skorecki
Pageof 14

Showing results (1-10 of 134) with videos related to

Sort By:
Pageof 14
Journal of the American Society of Nephrology : JASN|June 16, 2018
Leveraging Ancestral Heterogeneity to Map Shared Genetic Risk Loci in Pediatric Steroid-Sensitive Nephrotic SyndromeRebecca Hjorten, Karl Skorecki
Cells|July 11, 2025
Apolipoprotein L1 (APOL1): Consideration of Molecular Evolution, Interaction with APOL3, and Impact of Splice Isoforms Advances Understanding of Cellular and Molecular Mechanisms of Cell InjuryRazi Khalaila, Karl Skorecki
Nature Reviews. Nephrology|March 24, 2019
Introducing routine genetic testing for patients with CKDAsaf Vivante, Karl Skorecki
Discovery Medicine|August 14, 2010
A novel experimental platform for investigating tumorigenesis and anti-cancer therapy in a human microenvironment derived from embryonic stem cellsMaty Tzukerman, Karl Skorecki
Human Genetics|October 12, 2012
The population genetics of the Jewish peopleHarry Ostrer, Karl Skorecki
Lancet (London, England)|May 13, 2017
Israel: health and beyondKarl Skorecki, Richard Horton
Lancet (London, England)|November 7, 2024
Concerns regarding Gaza mortality estimatesRafael Beyar, Karl Skorecki
Kidney International|May 25, 2018
"Biomarking" the transition from genetic risk to kidney diseaseEtty Kruzel-Davila, Karl Skorecki
Clinical Journal of the American Society of Nephrology : CJASN|June 7, 2014
Gene-gene and gene-environment interactions in apolipoprotein L1 gene-associated nephropathyBarry I Freedman, Karl Skorecki
Elife|July 4, 2017
The double-edged sword of evolutionEtty Kruzel-Davila, Karl Skorecki
Pageof 14